b

biosurfit

59 employees

Biosurfit develops breakthrough technologies that enable fast, precise and affordable blood analysis at the point of care.

Basic info

Industry

medical equipment manufacturing

Sectors

Medical Device
PoC testing
C-reactive protein
Diagnostics
clinical chemistry
Medical Devices
bloodcount
Point-of-Care
Surface Plasmon Ressonance (SPR)
hematology
Health Care
Technology
IVD
Medical
Diabetes
medical diagnostics
HbA1c
microfluidics
in vitro diagnostic
biotech

Date founded

2006

Funding rounds raised

Total raised

$11M

from 4 investors over 4 rounds

b

biosurfit raised $11M on December 14, 2018

Investors: PMEInvestimentos and Boule Diagnostics AB

b

biosurfit raised undisclosed on January 1, 2010

Investors: Caixa Capital, SCR, S.A.

b

biosurfit raised undisclosed on January 1, 2006

Investors: Portugal Ventures

FAQ